Recent posts

TypePostAuthorRepliesLast updated
Blog entryWTO Trade Policy Review: Members question the United States on compulsory licensing, Bayh-Dole, UNHLP & Section 337 thiru014 weeks 6 days ago
Blog entryWTO: Spotlight on the United States at the Trade Policy Review (December 2012) thiru015 weeks 4 hours ago
Blog entryRejected letter to Foreign Affairs, responding to "Healthy Governance" article about WHO James Love115 weeks 3 days ago
Blog entryEB140: WHO adopts decision on terms of reference for overall programme review of the GSPOA (31 Jan 2017) thiru016 weeks 1 day ago
Blog entryEB140 heats up during discussions of proposed changes to resolution on TOR of Overall Programme Review of GSPOA thiru016 weeks 4 days ago
Blog entryChilean Cámara de Diputados votes overwhelmingly to advance compulsory licensing of drug patents. Andrew Goldman016 weeks 6 days ago
PageZika James Love017 weeks 1 day ago
PageAntimicrobial resistance (AMR) James Love017 weeks 1 day ago
Blog entryKEI proposal for Antibiotics Innovation Funding Mechanism (AIFM), shortlisted for demonstration project by WHO's EURO region James Love017 weeks 1 day ago
Blog entryEB140: Statement of India on the Report of the United Nations High-Level Panel on Access to Medicines thiru017 weeks 2 days ago
PageDr. Diane Singhroy, Scientific and Technical Advisor Claire Cassedy017 weeks 6 days ago
Blog entryGroups Object to Army Proposal to Give Sanofi a Monopoly on Patents for Taxpayer-Funded Zika Vaccine James Love017 weeks 6 days ago
Blog entryKlobuchar Drug Importation Amendment Sees Votes Crossing the Aisle Zack Struver018 weeks 5 days ago
Blog entryKEI initial opposition to U.S. Army grant of exclusive license to Sanofi on patents for Zika virus vaccine KEI Staff018 weeks 6 days ago
PageBackground FAQ on Glivec (imatinib) compulsory license in Colombia Zack Struver022 weeks 36 min ago
Blog entryColombia finalizes 44% price reduction of leukemia drug Glivec Andrew Goldman022 weeks 42 min ago
Blog entrySCP25: Closing Statement of the Republic of South Africa thiru022 weeks 6 hours ago
Blog entryFront page New York Times story explores Kite Pharma's profitable relationship with NIH regarding expensive cancer drug Zack Struver022 weeks 23 hours ago
PageNIH licenses (patents, data) and comments on proposed exclusive licenses James Love022 weeks 1 day ago
Blog entry2016: KEI Comments on NIH Proposed Exclusive License to Kite Pharma for Cancer Treatment Claire Cassedy022 weeks 1 day ago
Blog entryKEI Dec 9, 2016 comments to NIST on Bayh-Dole Act Regulations James Love022 weeks 4 days ago
Blog entrySCP25: South Africa’s Experience Related to the Topic of Access to Medicines thiru023 weeks 2 hours ago
Blog entryPCB39: Address of Justice Michael Kirby - HIV/AIDS & Solidarity - 30 Years On thiru023 weeks 7 hours ago
Blog entrySCP25: Statement of Asia Pacific Group on Patents and Health thiru023 weeks 23 hours ago
Blog entrySCP25: Statement of the Republic of South Africa on Patents and Health thiru023 weeks 23 hours ago